Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C
Second Department of Internal Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
Hepatology. 1995 Jul;22(1):30-5.
Hepatitis C virus (HCV) populations in vivo exist as a mixture of heterogeneous viruses called quasispecies, which have variations in the hypervariable region (HRV). However, the relationship between the diversity of HVR quasispecies, the disease stage, or the interferon (IFN) responsiveness remains to be elucidated. To study these, serum samples were obtained from 42 patients with chronic hepatitis C virus infection; 24 with chronic active hepatitis (CAH) treated with IFN, 9 with cirrhosis, 9 with hepatocellular carcinoma (HCC). HCV quasispecies populations were separated by the single-strand conformation polymorphism (SSCP) method targeted to the HVR. The patients were classified into two groups; a single-band group (n = 12) in which HVR quasispecies was homogeneous and a multiple-band group (n = 30) in which HVR quasispecies was heterogeneous. Patients with multiple bands had significantly more advanced liver disease than those with a single-band group (P = .0082). The percentage of patients with single band were 41% in CAH, 22% in cirrhosis, and 0% in HCC. Multivariate analyses showed that viral diversity was independently related to the progression of liver disease and was not correlated with the duration of infection. We also found that in CAH, the patients who had multiple bands (n = 14) were more resistant to IFN therapy than those who had a single band (n = 10) (P = .002). These results indicate that the diversity of HCV quasispecies becomes more complex as the disease stage progresses and that CAH with more complex diversity shows less IFN effectiveness.
丙型肝炎病毒(HCV)在体内以称为准种的异质病毒混合物形式存在,这些病毒在高变区(HRV)存在变异。然而,HRV准种的多样性与疾病阶段或干扰素(IFN)反应性之间的关系仍有待阐明。为了研究这些关系,从42例慢性丙型肝炎病毒感染患者中获取血清样本;其中24例为接受IFN治疗的慢性活动性肝炎(CAH)患者,9例为肝硬化患者,9例为肝细胞癌(HCC)患者。通过针对HVR的单链构象多态性(SSCP)方法分离HCV准种群体。将患者分为两组;一组为单带组(n = 12),其中HVR准种是同质的,另一组为多带组(n = 30),其中HVR准种是异质的。多带组患者的肝病进展明显比单带组患者更严重(P = .0082)。单带患者在CAH中的比例为41%,在肝硬化中为22%,在HCC中为0%。多变量分析表明,病毒多样性与肝病进展独立相关,与感染持续时间无关。我们还发现,在CAH中,多带患者(n = 14)比单带患者(n = 10)对IFN治疗更具抗性(P = .002)。这些结果表明,随着疾病阶段的进展,HCV准种的多样性变得更加复杂,并且具有更复杂多样性的CAH显示出较低的IFN有效性。